Navigation Links
14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
Date:2/10/2009

The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 in Philadelphia. The dynamic two-day event will feature distinguished speakers and panelists from Healthcare Services, Investment, Pharma, Biotech, and Medical Device sectors.

Philadelphia, PA (PRWEB) February 10, 2009 -- The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 at the Park Hyatt Hotel at The Bellevue in Philadelphia, PA. Distinguished speakers and panelists from across the health care industry include:


  • Wayne Gattinella - President, CEO, Director, WebMD
  • John Hammergren - Chairman, President, CEO, McKesson
  • Michael McCallister - President, CEO, Humana
  • Israel Makov - Chairman, Given Imaging, Former CEO, Teva Pharmaceuticals
  • Kent Thiry - Chairman, CEO, DaVita
  • Ronald Paulus - Executive Vice President, CTO, CIO, Geisinger Health System

Discussion Panel Sessions offered include:
  • The Blurring Line Between Pharma and Biotech - Featuring panelists from Wyeth, Pfizer, Amgen, Bank of America Merrill Lynch Securities, Orbimed, and Booz & Co.
  • Overcoming Hurdles: Financing Growth In A Capital Constrained World - Featuring panelists from JP Morgan, Aisling Capital, Johnson & Johnson Development Corporation, Cain Brothers & Co., and Deloitte Consulting
  • Policy: Will Reform Become Reality? - Featuring panelists from Independence Blue Cross, Putnam Associates, American Medical Association, New America Foundation, and McKinsey
  • The Global Market's Impact On Medical Devices - Featuring panelists from Synthes, Abbott Vascular, Johnson & Johnson Medical Brazil, Angel Medical Systems, and Boston Consulting Group
  • New Paradigms for Venture Financing: The Future Of Early Stage Investment - Featuring panelists from NEA, Novartis Options Fund, Polaris Ventures, Forward Ventures, CHL Medical Partners, and Pulmatrix

The Focus On Innovation Session will bring together promising start-ups and venture capitalists in a dynamic forum. This year's advisory board include investors from Johnson & Johnson Development Corporation, SR One, Quaker Bioventures, Safeguard, New Leaf Venture Partners, Domain Associates, 5Am Ventures, and Cardinal Partners.

About Wharton Health Care Business Conference:
Now in its 14th year, the conference has grown to become a leading health care forum for industry professionals, policy makers academics, and students. The annual two-day event typically draws over 600 attendees from across the nation. Attendees represent a broad range of functions including Business Development, Marketing, Corporate Strategy, Finance, and Clinical. To register and learn more about the conference, visit www.whcbc.org.

Media Contact:
Lynn Wang
WHCBC Co-Chair
info (at) whcbc (dot) org

###

Read the full story at http://www.prweb.com/releases/Wharton_Health_Care/Business_Conference/prweb1995514.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
2. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
3. Sunesis to Present at the 11th Annual BIO CEO & Investor Conference
4. Alexzas Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
5. Advanced Life Sciences to Present at the 11th Annual BIO CEO & Investor Conference
6. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
7. MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
8. Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference
9. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
10. Indevus Pharmaceuticals Announces Release of 2008 Annual Report
11. Cell Therapeutics, Inc. (CTI) to Present at 11th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
(Date:2/24/2017)... SAN DIEGO , Feb. 24, 2017  Aethlon ... the following note authored by its Chairman and CEO, ... address at the Munich Security Conference last Saturday, ... engineered virus could kill more people than nuclear weapons. ... by U.S. and U.K. intelligence agencies, that scientific terrorists ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... leading digital health company, and Digital Noema ... and remote patient monitoring, announce they are partnering ... DN Telehealth maximizes collaboration compatibility for ... consultations beyond a physical clinical setting to include ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
Breaking Biology News(10 mins):